Novavax Upgraded To Overweight From Neutral At Piper Jaffray
November 26, 2018 at 07:38 AM EST
Piper Jaffray analyst Edward Tenthoff upgraded Novavax to Overweight from Neutral and doubled his price target for the shares to $4 from $2.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.